Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial

James M. Foran, Zhuoxin Sun, Selina M. Luger, David F. Claxton, Hillard M. Lazarus, Daniel A. Arber, Jacob M. Rowe, Elisabeth Paietta, Janis Racevskis, Fran Garrett-Bakelman, Yanming Zhang, Jessica K. Altman, Aref Al-Kali, Hong Zheng, Keith W. Pratz, E. Randolph Broun, Bayard L. Powell, Kristen Marie O’Dwyer, John E. Godwin, Yishai Ofran, Mark R. Litzow, Martin S. Tallman

Open source

DOI: 10.1016/j.bneo.2026.100194
Published: 2026-05
Container: Blood Neoplasia
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.bneo.2026.100194,
  title = {Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial},
  author = {James M. Foran and Zhuoxin Sun and Selina M. Luger and David F. Claxton and Hillard M. Lazarus and Daniel A. Arber and Jacob M. Rowe and Elisabeth Paietta and Janis Racevskis and Fran Garrett-Bakelman and Yanming Zhang and Jessica K. Altman and Aref Al-Kali and Hong Zheng and Keith W. Pratz and E. Randolph Broun and Bayard L. Powell and Kristen Marie O’Dwyer and John E. Godwin and Yishai Ofran and Mark R. Litzow and Martin S. Tallman},
  year = {2026},
  journal = {Blood Neoplasia},
  doi = {10.1016/j.bneo.2026.100194},
  url = {https://doi.org/10.1016/j.bneo.2026.100194}
}

RIS

TY  - JOUR
TI  - Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial
AU  - James M. Foran
AU  - Zhuoxin Sun
AU  - Selina M. Luger
AU  - David F. Claxton
AU  - Hillard M. Lazarus
AU  - Daniel A. Arber
AU  - Jacob M. Rowe
AU  - Elisabeth Paietta
AU  - Janis Racevskis
AU  - Fran Garrett-Bakelman
AU  - Yanming Zhang
AU  - Jessica K. Altman
AU  - Aref Al-Kali
AU  - Hong Zheng
AU  - Keith W. Pratz
AU  - E. Randolph Broun
AU  - Bayard L. Powell
AU  - Kristen Marie O’Dwyer
AU  - John E. Godwin
AU  - Yishai Ofran
AU  - Mark R. Litzow
AU  - Martin S. Tallman
PY  - 2026
JO  - Blood Neoplasia
DO  - 10.1016/j.bneo.2026.100194
UR  - https://doi.org/10.1016/j.bneo.2026.100194
ER  -

APA

Foran, J. M., Sun, Z., Luger, S. M., Claxton, D. F., Lazarus, H. M., Arber, D. A., Rowe, J. M., Paietta, E., Racevskis, J., Garrett-Bakelman, F., Zhang, Y., Altman, J. K., Al-Kali, A., Zheng, H., Pratz, K. W., Broun, E. R., Powell, B. L., O’Dwyer, K. M., Godwin, J. E., Ofran, Y., Litzow, M. R., & Tallman, M. S. (2026). Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial. Blood Neoplasia. https://doi.org/10.1016/j.bneo.2026.100194

Source records

crossref · retrieved 2026-09-26T18:21:40.622Z